Patents by Inventor Sarah L. Morgan

Sarah L. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lubricating oil composition with viscosity modifier based on syndiotactic propylene-based ethylene- propylene copolymers with improved properties
    Patent number: 11926802
    Abstract: Provided is a lubricating oil composition that includes a major amount of a lubricant base oil and a minor amount of a viscosity index improver comprising a syndiotactic propylene-based ethylene-propylene copolymer comprising: a) 2 to 20% by weight of ethylene, b) 80 to 98% by weight of propylene; c) 50 to 99% of rr triads; and d) Mw (LS) of 10 to 250 kg/mol.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: March 12, 2024
    Assignees: EXXONMOBIL CHEMICAL PATENTS INC., CHEVRON ORONITE COMPANY LLC
    Inventors: Sara Yue Zhang, Maryam Sepehr, David L. Morgan, Jingwen Zhang, Jo Ann M. Canich, Peijun Jiang, John R. Hagadorn, Chase A. Eckert, Sarah J. Mattler, Shuhui Kang, Pritesh Arjunbhai Patel
  • Controlled Release Formulations
    Publication number: 20130273140
    Abstract: The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
    Type: Application
    Filed: June 11, 2013
    Publication date: October 17, 2013
    Inventors: Edward T. Maggio, Elias Meezan, Dennis J. Pillion, Sarah L. Morgan, Joe Baggott
  • Controlled release formulations
    Patent number: 8470370
    Abstract: The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: June 25, 2013
    Assignees: Aegis Therapeutics, LLC, The UAB Research Foundation
    Inventors: Edward T. Maggio, Elis Meezan, Dennis J. Pillion, Sarah L. Morgan, Joe Baggott
  • Controlled release formulations
    Patent number: 8329220
    Abstract: The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: December 11, 2012
    Assignees: Aegis Therapeutics, LLC, The UAB Research Foundation
    Inventors: Edward T. Maggio, Elias Meezan, Dennis J. Pillion, Sarah L. Morgan, Joe Baggott
  • CONTROLLED RELEASE FORMULATIONS
    Publication number: 20090110735
    Abstract: The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
    Type: Application
    Filed: August 22, 2008
    Publication date: April 30, 2009
    Inventors: Edward T. Maggio, Elias Meezan, Dennis J. Pillion, Sarah L. Morgan, Joe Baggott
  • Compositions containing an inhibitor of dihydrofolate reductase and a folate
    Publication number: 20020037899
    Abstract: The deleterious symptoms of autoimmune disease in a patient suffering from symptoms of autoimmune disease can be relieved by by co-administration of a cell-mediated immune inhibiting effective amount of at least one inhibitor of dihydrofolate reductase and a folate wherein the folate is formulated for delayed release in a carrier.
    Type: Application
    Filed: August 9, 2001
    Publication date: March 28, 2002
    Inventors: Joseph E. Baggott, Sarah L. Morgan